BioView

BioView is a biotechnology startup that specializes in developing an advanced automated cell diagnostic system tailored for cytogenetics, pathology, and cytological labs. Their groundbreaking Duet™ platform offers automated detection, classification, analysis, and counting of targeted cells for diagnostic and research purposes. With the utilization of bright light illumination for cell morphology and chromosomal analysis, as well as fluorescent illumination for protein and genetic studies, BioView's innovation is at the forefront of precision in cell diagnostics.

Founded in 2000, BioView has positioned itself at the intersection of biotechnology and healthcare, catering to the needs of laboratories in these domains. The company's core strength lies in its fully motorized fluorescent and bright-field microscope, which features a high-resolution camera managed by proprietary imaging, analysis, and review software.

Overall, BioView's groundbreaking technology and innovation have the potential to revolutionize diagnostic processes in laboratories, offering a more efficient and precise approach to cell diagnostics. With the increasing demand for advanced diagnostic solutions, BioView is well-positioned to make a significant impact in the biotechnology and healthcare industries.